Shares in BridgeBio were ticking up today after it revealed data from its phase 3 trial of infigratinib in achondroplasia, ...
TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...
Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...
Q4 2025 Earnings Call February 11, 2026 4:30 PM ESTCompany ParticipantsChad Fugure - Vice President of Investor ...
Home Markkula Center for Applied Ethics Focus Areas Business Ethics Business Ethics Resources IKEA Case: One Company’s Fight to End Child Labor Empty garage with a highlighted walking path in front of ...
Vedder Price attorney Javier Lopez represented an investor who accused an Akerman attorney of botching a set of leases tied to an investment opportunity. Then Akerman contended he defamed the firm in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results